Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma
Clinical trial NCT02191930 · COMPLETED
Trial details
- NCT number
- NCT02191930
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2022-03-16
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.